Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Food Funct ; 7(4): 1814-24, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26583652

ABSTRACT

Indigestible carbohydrates may improve obesity. Spent turmeric contains high levels of dietary fibre and resistant starch (RS), which have fermentation potential in vitro. We hypothesised that indigestible carbohydrates in spent turmeric might prevent obesity development. In the first study, rats were administered 10% turmeric powder (TP) or spent turmeric powder (STP) in a high-fat (HF) diet for 28 d. In the second study, rats were fed 10% STP in a HF diet with or without antibiotics for 15 d. In the third study, rats were treated with a STP-containing suspension. In study 1, the TP and STP diet increased the caecal short-chain fatty acid (SCFA) content compared to that of a control diet. The lower energy intake in the TP and STP group was strongly related to the decrease in visceral fat weight. In study 2, after caecal fermentation suppression with antibiotics, STP treatment decreased the visceral fat mass. In study 3, the plasma glucose levels and incremental area under the curve (AUC) after ingestion of a STP-containing suspension were lower than those after ingestion of suspension alone. These findings suggest the reduction of carbohydrate absorption during the gastrointestinal passage after TP and STP treatment. Our data indicate that the reduced obesity development in rats fed a HF diet may be attributed to the low metabolisable energy density of carbohydrates in the spent turmeric, independent of SCFA-mediated factors.


Subject(s)
Curcuma/metabolism , Dietary Fats/metabolism , Obesity/diet therapy , Animals , Cecum/metabolism , Diet, High-Fat/adverse effects , Dietary Carbohydrates/metabolism , Dietary Fats/adverse effects , Energy Intake , Fatty Acids, Volatile/metabolism , Humans , Male , Obesity/metabolism , Rats , Rats, Sprague-Dawley
2.
J Med Food ; 14(3): 240-6, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21332403

ABSTRACT

In the present study, we investigated the effects of gallic acid (GA) (3,4,5-trihydroxybenzoic acid), a polyhydroxyphenolic compound, isolated from Rhus chinensis, on the human monocytic lymphoma cell line U937. In vitro experiments showed that treating U937 cells with various amounts of GA inhibited cell viability and induced apoptosis in a dose-dependent manner. In order to understand the mechanism by which GA induces apoptosis, we examined the gene expression of p53, nuclear factor κB (NF-κB), and inhibitor of NF-κB (I-κB) after treating the cells with GA and found that expression levels of the genes for p53 and NF-κB increased and that for I-κB decreased. The results obtained from western blotting with U937 cells showed up-regulation of NF-κB protein and down-regulation of proliferating cell nuclear antigen and I-κB protein. These results demonstrate that GA efficiently induces apoptosis in U937 cells and that GA is a potential chemotherapeutic agent against lymphoma.


Subject(s)
Antineoplastic Agents, Phytogenic/therapeutic use , Gallic Acid/therapeutic use , Gene Expression Regulation/drug effects , Lymphoma/drug therapy , Monocytes/drug effects , Phytotherapy , Rhus/chemistry , Antineoplastic Agents, Phytogenic/pharmacology , Apoptosis/drug effects , Cell Survival/drug effects , Dose-Response Relationship, Drug , Gallic Acid/pharmacology , Humans , I-kappa B Proteins/genetics , I-kappa B Proteins/metabolism , Lymphoma/genetics , Lymphoma/metabolism , Monocytes/physiology , NF-kappa B/genetics , NF-kappa B/metabolism , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Proliferating Cell Nuclear Antigen/genetics , Proliferating Cell Nuclear Antigen/metabolism , U937 Cells
3.
Lipids ; 46(3): 287-95, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21076944

ABSTRACT

Prostate cancer is the second leading cause of male deaths due to cancer in the United States. Hydrogenated vegetable oils have been suspected of inducing adverse health effects, including atherosclerosis and cancer. Here we report that a selectively hydrogenated soybean oil (SHSO) containing a high quantity of conjugated linoleic acids showed remarkably strong anticarcinogenic activity against prostate cancer in the rat model (Copenhagen rats with MAT-LyLu syngeneic rat prostate cancer cells) study in vivo and human prostate carcinoma cell lines studies in vitro, as compared with native soybean oil. A 5% dietary supplementation with SHSO inhibited the growth of prostate cancer by 80% in vivo. The TUNEL method and immunohistochemical staining assays of bax, bcl-2, and survivin clearly showed that SHSO induced prostate cancer cell apoptosis in the tested rats. DNA fragmentation analysis in vitro further confirmed the apoptotic activity of SHSO on the MAT-LyLu prostate cancer cells. The SHSO also showed strong cytotoxicity on human prostate cancer cells (DU145 and PC3). This represents the first report demonstrating the significant anticancer activities of hydrogenated vegetable oils at low levels of dietary supplementation.


Subject(s)
Antineoplastic Agents/pharmacology , Carcinoma/pathology , Cell Proliferation/drug effects , Prostatic Neoplasms/pathology , Soybean Oil/pharmacology , Animals , Apoptosis/drug effects , Carcinoma/diet therapy , Cell Line, Tumor , DNA Fragmentation/drug effects , Humans , Hydrogenation , In Situ Nick-End Labeling , Male , Neoplasm Transplantation , Prostatic Neoplasms/diet therapy , Rats , Soybean Oil/chemistry , Soybean Oil/therapeutic use
4.
Arch Pharm Res ; 33(4): 545-50, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20422363

ABSTRACT

Three compounds were isolated from the ethyl acetate soluble fraction of the methanolic extract of the leaves of Catalpa ovata (Bignoniaceae) through repeated column chromatography. We investigated the effects of these compounds on T cell-mediated responses for tumor surveillance and proliferation in U937, HL60, and Molt-4 leukemia cells. Compounds 1-3 inhibited proliferation of those cells in a dose-dependent manner. Compound 3 showed mild effect in Molt-4 cell cytotoxicity. Compound 3 enhanced gene expressions of p53 and IL-4, but decreased IL-2 and IFN-Gamma genes in Molt-4 cell. Our findings indicate that compound 3 may enhance T cell-mediated immune responses and anticancer properties.


Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Bignoniaceae/chemistry , Immunity, Cellular/drug effects , Plant Extracts/isolation & purification , Plant Extracts/pharmacology , T-Lymphocytes/drug effects , Antineoplastic Agents, Phytogenic/isolation & purification , Apoptosis/drug effects , Apoptosis/genetics , Apoptosis/immunology , Cell Proliferation/drug effects , Cell Survival/drug effects , Cytokines/biosynthesis , Cytokines/immunology , Dose-Response Relationship, Drug , Enzyme-Linked Immunosorbent Assay , Gene Expression/drug effects , HeLa Cells , Humans , Immunity, Cellular/immunology , Medicine, Korean Traditional , Molecular Structure , Plant Leaves/chemistry , Reverse Transcriptase Polymerase Chain Reaction , T-Lymphocytes/immunology , U937 Cells
5.
Arch Pharm Res ; 31(11): 1399-404, 2008 Nov.
Article in English | MEDLINE | ID: mdl-19023535

ABSTRACT

Methanol extracts of the root of Dipsacus asper Wall (Dipsacaceae) were found to exhibit apoptosis-inducing activities in U937 (human monocyte-like histiocytic) cells. Investigation of the active n-BuOH fraction led to the isolation of akebia saponin D (ASD). Structure was established by spectroscopic methods. Treatment of U937 cells with ASD induced apoptosis in a dose dependent manner. ASD exerted strong cytotoxicity against human and murine leukemia cells. It is significantly increased the subG1 cell population and expression of p53 and Bax gene. And also ASD enhanced NO production from RAW264.7 macrophage cells. Taken together, these results strongly indicate that ASD may exert apoptosis-inducing activity via induction of apoptosis through activation chiefly via the nitric oxide and apoptosis-related p53 and Bax gene expression. These data provide scientific evidence that Dipsacus asper Wall can be useful as a chemopreventive agent.


Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Apoptosis/drug effects , Dipsacaceae/chemistry , Saponins/pharmacology , Antibiotics, Antineoplastic/pharmacology , Antineoplastic Agents, Phytogenic/isolation & purification , Cell Survival/drug effects , DNA Fragmentation/drug effects , Dose-Response Relationship, Drug , Doxorubicin/pharmacology , Drug Screening Assays, Antitumor , Gene Expression/drug effects , Genes, p53/drug effects , Humans , Models, Molecular , Molecular Conformation , Nitric Oxide/biosynthesis , Nitric Oxide/physiology , Plant Roots/chemistry , Reverse Transcriptase Polymerase Chain Reaction , Saponins/isolation & purification , U937 Cells , bcl-2-Associated X Protein/genetics
6.
J Biochem Mol Biol ; 40(4): 459-66, 2007 Jul 31.
Article in English | MEDLINE | ID: mdl-17669260

ABSTRACT

The cDNA sequence of the Japanese flounder (Paralychthys olivaceus) IgD has been previously reported (GenBank accession no. AB052658) and this was followed by the detection of IgD mRNA expression in some flounder organ tissues. However, it has not been determined whether the flounder IgD gene is virtually expressed into IgD protein. To characterize the flounder immunoglobulins utilized in elucidating the mechanism, evolution and diversity of the flounder immune system, antibodies specific to IgD and IgM were necessary. In the present study, partial flounder recombinant IgD (rIgD), IgM (rIgM) and the conserved regions of IgD and IgM (rCIg) were produced by cloning the cDNA sequence using isotype specific primers which were designed to produce unique fragments of IgD and IgM specific amino acid sequences. The production of recombinant Igs was ascertained by SDS-gel electrophoresis and immunoblot analysis using anti-T7 d Taq antibody. The produced recombinant Igs were purified using affinity columns, and used as immunogens. Antibodies specific to the isotype of flounder Igs were generated by immunizing rabbits with rfIgs and the antibodies produced were identified by enzyme-linked immunosorbent assay (ELISA) and immunoblotting. Specificities of the generated antibodies were evaluated by testing cross-reactivity between recombinant IgM and IgD. By ELISA, rabbit antibodies against the rfIgD fragment (anti-rfIgD) failed to recognize any kind of flounder serum Igs, whereas respective antibodies against rfCIg (anti-rfCIg) and rfIgM fragments (anti-rfIgM) reacted with serum Igs. Likewise, in immunoblot assays, though anti-rfIgD did not, both anti-rfCIg and anti-rfIgM bound with the ~85 kd flounder IgM heavy chain. By flow cytometry analysis, anti-rfCIg, anti-rfIgD and anti-rfIgM reacted with 6%, 3% and 6.5% of cells, respectively, suggesting that flounder IgD is not secreted in serum but expressed on flounder B-like cell surfaces as in mammals. Antibodies produced against recombinant flounder Igs could be used to develop sandwich assay systems for detecting flounder Igs and for further investigating the flounder immune system.


Subject(s)
Flounder/genetics , Immunoglobulin D/biosynthesis , Immunoglobulin D/genetics , Animals , Antibodies/immunology , Antibody Specificity/immunology , Cell Separation , Cloning, Molecular , DNA, Complementary , Enzyme-Linked Immunosorbent Assay , Flow Cytometry , Genetic Vectors , Immunoglobulin D/isolation & purification , Immunoglobulin M/isolation & purification , Immunoglobulin M/metabolism , Kidney/cytology , Molecular Sequence Data , Recombinant Proteins/isolation & purification
7.
Arch Pharm Res ; 30(4): 408-11, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17489354

ABSTRACT

We have isolated a new prenylated chalcone from the roots of Sophora flavescens (Leguminosae). We determined that structure of this compound is 7,9,2',4'-tetrahydroxy-8-isopentenyl-5-methoxychalcone (1) on the basis of spectroscopic analysis (1D and 2D NMR data). Compound 1 exhibited potent cytotoxicity against human acute promyelocytic (HL60), mouse lymphocytic (L1210) and human histiocytic (U937) leukemia cells.


Subject(s)
Antineoplastic Agents, Phytogenic/isolation & purification , Chalcones/isolation & purification , Sophora/chemistry , Animals , Antineoplastic Agents, Phytogenic/pharmacology , Cell Line, Tumor , Chalcones/chemistry , Chalcones/pharmacology , Humans , Magnetic Resonance Spectroscopy , Mice , Protein Prenylation
8.
J Med Food ; 7(1): 19-23, 2004.
Article in English | MEDLINE | ID: mdl-15117548

ABSTRACT

In the present work we investigated the effects of brown rice extracts on proliferation and apoptosis of cancer cells. Brown rice extracts were prepared using nongerminated brown rice versus germinated brown rices. Mouse leukemia L1210 cells, human acute lymphoblastic leukemia Molt4 cells, and human cervical cancer HeLa cells were treated with either nongerminated brown rice extract (N ex), water-germinated extract (W ex), chitosan-germinated extract (C ex), glutamic acid-germinated brown rice extract (G ex), or chitosan/glutamic acid-germinated brown rice extract (CG ex). The concentrations of gamma-aminobutyric acid (GABA) in the G ex and CG ex were three and 3.3 times higher than the GABA concentration in the N ex, respectively. The G ex and CG ex retarded significantly the proliferation rates of L1210 and Molt4 cells, and the highest retardation rate was with CG ex. In addition, the G ex and CG ex enhanced significantly apoptosis of the cultured L1210 cells, but no significant apoptosis was seen with the other extracts, which have lower concentrations of GABA than G ex and CG ex. These results show that brown rice extracts with enhanced levels of GABA have an inhibitory action on leukemia cell proliferation and have a stimulatory action on the cancer cell apoptosis.


Subject(s)
Apoptosis/drug effects , Germination , Neoplasms/prevention & control , Oryza , Plant Extracts/pharmacology , gamma-Aminobutyric Acid/pharmacology , Animals , Cell Division/drug effects , Female , HeLa Cells , Humans , Leukemia L1210 , Mice , Neoplasms/pathology , Plant Extracts/therapeutic use , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...